Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Earth Science Tech, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2014
FY2019
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Revenue
0.08
0.46
0.77
0.53
0.14
0.01
0.05
12
33.1
35.7
Cost of revenue
0.08
0.27
0.48
0.31
0.1
0.02
0.03
4.13
8.82
10.2
Gross profit
0
0.19
0.3
0.22
0.04
-0.01
0.02
7.83
24.3
25.5
Research and development
0.03
0.15
0.34
0.08
0.01
0
0
Selling, general and administrative
0.23
0.17
4.15
3.57
Selling and marketing
0.67
0.33
0.24
0.05
0
0.01
0.03
0.84
2.84
General and administrative
0.12
0.65
0.51
0.55
0.23
0.12
0.23
Operating expenses
8.77
1.9
2.43
1.13
4.34
0.22
0.96
6.94
20.9
22.2
Operating income
-8.77
-1.71
-2.14
-0.91
-4.3
-0.23
-0.94
0.89
Interest expense
0
0
0.08
0
0
0.09
0.05
0.07
0.02
0.02
Interest income
0
Other non-operating income
-0
-0.08
-0.29
-0.08
3.4
0.57
-0.07
0.07
Pre-tax income
-8.77
-1.71
-2.22
-1.2
-4.38
3.17
-0.37
0.83
3.37
3.09
Income tax
0.01
0.12
-0.51
Net income to minority interests
-0.03
Net income
-8.77
-1.71
-2.22
-1.2
-4.38
3.17
-0.37
0.81
3.25
3.63
EBITDA
-8.76
-1.69
-2.13
-0.9
-4.3
-0.23
-0.92
1.04
EPS, basic
-0.23
-0.04
-0.04
-0.03
-0.08
0.06
-0.00
0.00
0.01
0.01
EPS, diluted
-0.23
-0.04
-0.04
-0.03
-0.08
0.06
-0.00
0.00
0.01
0.01
Shares, basic (weighted)
36.8
53.9
146
310
304
293
Shares, diluted (weighted)
36.8
53.9
146
310
304
293
Balance sheet
FY2014
FY2019
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Cash and equivalents
0.32
0.07
0.13
0.03
0.02
0.03
0.04
0.7
1.47
0.8
Receivables
0.07
0.07
0.04
0.01
0
0.24
0.13
0.36
Inventory
0.16
0.06
0.02
0.01
0.32
0.5
0.68
Other current assets
0.1
0.01
0.03
0
0.36
0.15
Total current assets
0.66
0.28
0.39
0.13
0.04
0.03
0.05
1.26
3.11
3.72
Property, plant and equipment
0.07
0.02
0.01
0
0
0.14
0.14
1.38
1.52
Lease right-of-use assets
0.01
0.01
0
0.2
0.16
0.17
0.1
Goodwill
2.3
2.3
2.3
2.65
Intangible assets
0.04
0.04
0.03
0.1
0.21
Other non-current assets
0.02
0.02
0.05
2.65
Total assets
0.77
0.35
0.41
0.15
0.06
0.08
2.73
3.88
7.07
8.97
Accounts payable
0.09
0.08
0.1
0.08
0.17
0.2
0.52
0.53
0.49
0.68
Accrued liabilities
0.09
0.09
0.15
0.23
0.31
0.12
0.85
2.32
1.15
Short-term debt
0.78
0.6
0.03
0.18
Total current liabilities
0.15
0.47
0.62
0.98
5.09
1.88
1.31
1.49
3.15
1.93
Long-term debt
0.2
0.06
Lease liabilities
0.1
0.08
0.04
Other non-current liabilities
0.06
Total liabilities
0.15
0.47
0.62
0.98
5.09
1.88
1.61
1.63
3.22
1.93
Total debt
0.78
0.81
0.09
Paid-in capital
22
25.3
27.4
28.1
28.2
28.3
31.3
31.6
31.5
30.8
Retained earnings
-21.4
-25.5
-27.7
-28.9
-33.3
-30.1
-30.5
-29.7
-27.7
-24.1
Treasury stock
-0.19
Shareholders' equity
0.63
-0.12
-0.21
-0.83
-5.03
-1.81
1.12
2.25
3.85
7.01
Minority interests
0.03
Total equity
0.63
-0.12
-0.21
-0.83
-5.03
-1.81
1.12
2.25
3.85
7.04
Total liabilities and equity
0.77
0.35
0.41
0.15
0.06
0.08
2.73
3.88
7.07
8.97
Shares outstanding
38.2
46.2
52.2
37.8
50.6
53.9
283
310
294
291
Cash flow statement
FY2014
FY2019
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Net income
-8.77
-1.71
-2.22
-1.2
-4.38
3.17
-0.37
0.81
3.25
3.6
Depreciation and amortization
0
0.02
0.01
0.01
0
0
0.02
0.15
0.15
0.28
Stock-based compensation
8.41
0.17
0.45
0.14
0
0
Deferred income tax
-0.26
-0.58
1.27
Change in receivables
-0.24
0.11
-0.23
Change in inventory
0.24
-0.03
-0.03
0.1
0.04
0.02
-0.31
-0.19
-0.14
Change in payables
0.09
-0.04
-0.01
0.35
0.35
0.11
-0.29
0.87
1.43
-0.97
Cash from operations
-0.38
-1.07
-1.64
-0.52
-0.2
-0.17
-1.01
1.21
4.37
1.94
Capital expenditures
-0.07
-0.03
-0.75
-0.76
Cash from investing
0
-0.03
-1.88
-1.9
Debt issued
0.18
Stock issued
0.57
0.97
1.56
0.22
0.06
0.05
0.56
0.11
Share buybacks
-0.18
-1.47
-0.47
Cash from financing
0.42
0.97
1.7
0.42
0.18
0.17
1.02
-0.52
-1.72
-0.71
Net change in cash
0.06
-0.1
-0.01
0.01
0
0.66
0.78
-0.68
Free cash flow
-0.45
1.18
3.62
1.18
Interest paid
0
0.05
0.07
0.02
0.02
Income taxes paid
0.03
0.15
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.09 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
71.4%
Gross profit / revenue.
Pre-tax margin
10.0%
Pre-tax income / revenue.
Net margin
10.8%
Net income / revenue.
Operating cash flow margin
6.4%
Cash from operations / revenue.
Return on equity (ROE)
53.0%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
37.5%
Net income / average total assets.
SG&A / revenue
10.2%
Selling, general and administrative expense / revenue.
D&A / revenue
0.8%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
7.8%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
802.6%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
202.5%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
4.9%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
949.3%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
263.9%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y
11.6%
Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y
9.1%
EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y
-55.6%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y
-67.3%
Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
82.0%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
84.3%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
26.9%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
48.7%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
168.3%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
-3.4%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
26.2%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.77x
Current assets / current liabilities.
Quick ratio
0.51x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.22x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
$0.01
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.12
Revenue / diluted weighted shares.
Operating cash flow per share
$0.01
Cash from operations / diluted weighted shares.
Book value per share
$0.03
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/E
6.88x
Market cap / net income. Only when net income is positive.
P/S
0.74x
Market cap / revenue.
P/B
3.64x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
5.96x
Market cap / tangible book value, when positive.
P/OCF
11.6x
Market cap / cash from operations, when positive.
EV/Sales
0.73x
Enterprise value / revenue.
Earnings yield
14.5%
Net income / market cap (the inverse of P/E).
Shareholder yield
2.9%
(Dividends paid + share buybacks) / market cap.
What was Earth Science Tech, Inc.'s revenue in fiscal 2026?
Earth Science Tech, Inc. reported revenue of $35.7M for fiscal 2026, 7.8% higher than the year before.
Was Earth Science Tech, Inc. profitable in fiscal 2026?
Yes. Net income was $3.6M, a net margin of 10.2%.
How much free cash flow did Earth Science Tech, Inc. generate in fiscal 2026?
Cash from operations of $1.9M minus capital expenditures of $756.6K left free cash flow of $1.2M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.